Education
About Us
Working with TipRanks
Follow Us
As Partners CO.,LTD. (JP:160A)
:160A
Top Page
As Partners CO.,LTD.
(160A)
Rating:80Outperform
Price Target:
¥3,715.00
▲(18.50% Upside)
As Partners CO.,LTD. (160A) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥11.48B
Dividend Yield1.72%
Average Volume (3M)19.72K
Price to Earnings (P/E)5.8
Beta (1Y)0.80
Revenue GrowthN/A
EPS GrowthN/A
CountryJP
EmployeesN/A
SectorServices
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)279.67
Shares Outstanding3,580,400
10 Day Avg. Volume15,920
30 Day Avg. Volume19,720
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥3,715.00Price Target Upside18.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
As Partners CO.,LTD. Business Overview & Revenue Model
Company Descriptionnull
How the Company Makes Moneynull
As Partners CO.,LTD. Financial Statement Overview
Summary
As Partners CO.,LTD. demonstrates strong revenue growth and improved profitability, supported by a stable balance sheet. However, the cash flow statement indicates challenges with free cash flow management. The company is on a positive growth trajectory with a need to address cash flow efficiency to sustain its financial health.Income Statement
As Partners CO.,LTD. has shown strong revenue growth over the years, with a notable increase from 2024 to 2025. The gross profit margin has improved, indicating efficient cost management. The net profit margin has also increased, reflecting enhanced profitability. EBIT and EBITDA margins have strengthened, showcasing operational efficiency. Overall, the income statement reflects a positive growth trajectory and profitability.85
Very Positive
Balance Sheet
The company's balance sheet shows a solid equity base with a growing stockholders' equity, indicating financial stability. The debt-to-equity ratio has increased, suggesting higher leverage but still within a manageable range. The equity ratio has improved, reflecting a stronger financial position. Overall, the balance sheet indicates stability with a cautious note on increasing leverage.78
Positive
Cash Flow
The cash flow statement reveals some challenges, with a decline in free cash flow due to significant capital expenditures. However, operating cash flow remains positive, indicating the company's ability to generate cash from operations. The free cash flow to net income ratio is negative, highlighting potential cash flow management issues. Overall, while operating cash flow is strong, the cash flow statement suggests a need for improved capital expenditure management.65
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 14.16B | 17.92B | 17.15B | 12.78B | 11.52B |
| Gross Profit | 3.22B | 3.86B | 3.11B | 2.15B | 1.87B |
| EBITDA | 1.01B | 1.64B | 1.08B | 552.06M | 1.02B |
| Net Income | 905.57M | 956.66M | 563.57M | 229.71M | 484.94M |
Balance Sheet | |||||
| Total Assets | 20.30B | 21.41B | 15.95B | 14.74B | 11.81B |
| Cash, Cash Equivalents and Short-Term Investments | 7.00B | 6.86B | 5.71B | 4.02B | 3.86B |
| Total Debt | 8.46B | 9.31B | 5.66B | 6.49B | 5.13B |
| Total Liabilities | 16.20B | 17.24B | 13.57B | 12.88B | 10.13B |
| Stockholders Equity | 4.10B | 4.16B | 2.38B | 1.86B | 1.68B |
Cash Flow | |||||
| Free Cash Flow | 0.00 | -3.29B | 2.19B | -1.86B | -1.06B |
| Operating Cash Flow | 0.00 | 1.31B | 3.43B | -745.18M | -338.97M |
| Investing Cash Flow | 0.00 | -4.65B | -1.43B | -707.64M | 928.45M |
| Financing Cash Flow | 0.00 | 4.46B | -884.25M | 1.31B | -369.06M |
As Partners CO.,LTD. Technical Analysis
Positive
3135.00
Price Trends
2882.22
Positive
2583.73
Positive
2178.72
Positive
Market Momentum
82.07
Positive
53.89
Neutral
18.18
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:160A, the sentiment is Positive. The current price of 3135 is below the 20-day moving average (MA) of 3184.00, above the 50-day MA of 2882.22, and above the 200-day MA of 2178.72, indicating a neutral trend. The MACD of 82.07 indicates Positive momentum. The RSI at 53.89 is Neutral, neither overbought nor oversold. The STOCH value of 18.18 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:160A.
As Partners CO.,LTD. Peers Comparison
Overall Rating
UnderperformOutperform
Sector (56)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥11.48B | 5.75 | 1.72% | ― | ― | ||
77 Outperform | ¥3.07B | 9.55 | 2.44% | -0.34% | -21.06% | ||
72 Outperform | ¥9.61B | 13.67 | 1.51% | 18.30% | 37.13% | ||
67 Neutral | ¥10.63B | 29.61 | ― | 11.69% | -38.92% | ||
66 Neutral | ¥11.12B | 20.61 | 1.15% | 20.37% | -5.97% | ||
63 Neutral | ¥5.67B | 7.95 | 4.08% | 8.95% | ― | ||
56 Neutral | $13.39B | 17.94 | 10.03% | 0.93% | 7.13% | -12.93% |
* Services Sector Average
Performance Comparison
JP:160A
As Partners CO.,LTD.
3,235.00
1,459.69
82.22%
JP:2373
Care Twentyone Corporation
421.00
31.99
8.22%
JP:2425
Care Service Co., Ltd.
826.00
6.07
0.74%
JP:6557
AIAI Group Corporation
1,603.00
-39.50
-2.40%
JP:7061
Japan Hospice Holdings Inc.
1,307.00
6.28
0.48%
JP:7133
HYUGA PRIMARY CARE Co.,Ltd.
1,327.00
10.91
0.83%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.